<DOC>
	<DOCNO>NCT02553239</DOCNO>
	<brief_summary>This clinical investigation evaluate safety cryoablation ( sclerotherapy muscle tissue heart freeze ) paroxysmal atrial fibrillation newly develop CoolLoop® cryoablation catheter . A aim investigation evaluation efficacy average duration applied procedure .</brief_summary>
	<brief_title>CoolLoop Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Pathologic Processes</mesh_term>
	<criteria>age 18 70 year symptomatic paroxysmal Atrial fibrillation ( AF ) minimum three episode paroxysmal AF least one episode paroxysmal AF within last 6 month document ECG sign date informed consent document patient female subject childbearing potential include , : agree use , able comply , effective contraception without interruption , study enrollment , throughout hospitalization 12 week catheter ablation leave atrial diameter &gt; 50 mm short axis assess transthoracic echocardiography advance structural heart disease include moderatetosevere valvular stenosis regurgitation , previous valve replacement valve repair , congenital heart disease , leave ventricular ejection fraction &lt; 45 % sinus rhythm , congestive heart failure New York Heart Association ( NYHA ) III IV , coronary artery bypass graft surgery within last 3 month chronic obstructive pulmonary disease treat betasympathomimetic drug severe respiratory insufficiency know bleed diathesis intolerance Heparin and/or intolerance oral anticoagulation previous AF ablation permanent pacemaker leave atrial thrombus intramural intracardiac thrombus tumor , condition may result difficulty advance CoolLoop® cryoablation catheter leave atrium access vascular system via right leave femoral vein possible transseptal puncture achieve due previous operation intervention interatrial septum ( e.g . closure patent foramen ovale atrial septal defect ) contraindication transesophageal echocardiography fluoroscopy impair renal function ( glomerular filtration rate &lt; 30 ml/min . ) history increase risk intracranial hemorrhage history cerebral ischemic stroke transient ischemic cerebral attack within last 180 day prior enrolment severe comorbidity hyperthyreosis condition , include presence laboratory abnormality , would place subject unacceptable risk / participate study confound ability interpret data study serious medical condition , laboratory abnormality , psychiatric illness would prevent subject signing Informed Consent Form pregnant lactating female severe condition , make patient unsuitable participate study , judge Investigator liveexpectancy &lt; 1 year patient active another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Paroxysmal</keyword>
	<keyword>Cryoablation</keyword>
</DOC>